VEENAT 400MG IMATINIB CAPSULES

Get a Price/Quote

VEENAT 400MG IMATINIB CAPSULES Specification

Origin
India

Salt Composition
Imatinib Mesylate 400mg

Dosage Form
Capsule

Ingredients
Imatinib Mesylate along with pharmaceutical excipients

Application
Oral anticancer therapy

Physical Color/Texture
Opaque blue and white capsules

Fermentation Smell
Odorless / characteristic medicine smell

Storage Instructions
Store below 30C, protect from moisture and light

Shelf Life
24 months

VEENAT 400MG IMATINIB CAPSULES Trade Information

Packaging Details
PA CK OF 30 CAPSULES

Main Domestic Market
All India

About VEENAT 400MG IMATINIB CAPSULES

VEENAT 400 MG TABLETS

AVAILABLE AS: 100 mg Capsules & 400 mg Tablets
Manufactured By: Natco

Specifications:-

Product Name:Veenat
Contains:Imatinib
Form:Capsules/Tablets
Strength:100mg & 400mg
Packing:100mg - Pack of 120 Capsules
:400mg - Pack of 30 Tablets

Note:- Veenat is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug................

Precise Targeted Cancer Therapy

VEENAT 400MG Imatinib Capsules deliver targeted oral treatment for select types of cancer in adults. Imatinib Mesylate, the active ingredient, disrupts abnormal cell growth and is administered under the guidance of a qualified oncologist. Its effectivity is recognized by various regulatory authorities worldwide, making it a reliable option for those in need of specialized cancer management.

Convenient Oral Dosage Form

VEENAT is available as capsules, allowing for straightforward oral administration. This dosage form provides ease of use for patients, eliminating the need for intravenous procedures and facilitating daily therapy. Each pack contains 30 capsules, enabling structured and manageable medication schedules.

Safe Storage and Handling

To maintain VEENAT 400MGs potency, store the capsules below 30C, away from moisture and light, in their original blister pack. With a shelf life of 24 months, proper storage ensures ongoing safety and efficacy. Always check expiry dates before use and consult your pharmacist for additional handling information.

FAQs of VEENAT 400MG IMATINIB CAPSULES:

Q: How should VEENAT 400MG Imatinib Capsules be taken for best results?

A: VEENAT 400MG capsules should be swallowed whole with water as directed by your oncologist, typically once daily. It is important to follow your prescribed schedule and any additional instructions regarding food intake or timing.

Q: What is the primary benefit of using VEENAT 400MG for cancer therapy?

A: The main benefit of VEENAT 400MG is its targeted action against abnormal cancer cell growth, providing an effective oral anticancer therapy option specifically formulated for adult patients.

Q: When should VEENAT 400MG not be used?

A: VEENAT 400MG is contraindicated in patients with known hypersensitivity to Imatinib Mesylate or any ingredient in the capsule. Do not start this medicine without a full evaluation and guidance from a qualified oncologist.

Q: Where can VEENAT 400MG capsules be obtained?

A: These capsules are available by prescription only through authorized distributors, exporters, suppliers, traders, and wholesalers in India. Always purchase from licensed outlets and ensure country-specific regulatory approvals are met.

Q: What is the process for starting treatment with VEENAT 400MG?

A: Initiating VEENAT 400MG requires a thorough diagnosis and prescription from a qualified oncologist. The doctor will assess your condition, discuss treatment goals, and monitor your response throughout therapy.

Q: How should VEENAT 400MG capsules be stored at home?

A: Store VEENAT 400MG capsules below 30C, protected from moisture and light, in the original blister pack. Avoid exposure to sunlight or high temperatures and keep out of reach of children.

Q: Is there any special warning associated with the use of VEENAT 400MG?

A: Yes, VEENAT 400MG must only be used under the supervision of a qualified oncologist due to the specific nature and potential risks associated with anticancer therapy.